New Spacelabs Healthcare Dual Display Monitor Launches

Friday, April 23, 2010

For immediate release

New Spacelabs Healthcare Dual Display Monitor Delivers Patient Monitoring & Workstation Performance in a Single, Cost-Effective Package

Issaquah, Wash., April 23, 2010 – Spacelabs Healthcare expands its patient monitoring portfolio by introducing the Ultraview 2900 with dual display capability. Clinicians can now simply and efficiently chart and access lab results on one display, while the other display remains dedicated to their patients’ real-time physiologic waveforms and alarms. With easy and immediate access to comprehensive information at the bedside monitor, there is no expensive workstation to purchase and maintain, plus there is less opportunity for infectious organisms to travel from bedside to bedside – unlike mobile workstations.

DNATM (Dynamic Network Access™), which functions like a Citrix thin-client, is embedded in the Spacelabs monitor and enables full access to all applications installed on a hospital’s Citrix server. Consistent with Spacelabs’ commitment to open architecture, DNA operates on a non-proprietary infrastructure and no additional hardware is required.  Because it’s easy to access information with DNA, clinicians can be assured of having the information needed to make critical clinical decisions as well as a convenient tool for sharing information with other caregivers – at the point-of-care.

“Our goal to improve the efficiency and accuracy of patient care is once again realized with the introduction of the SL2900. Not only does this new monitor support the needs of the highest acuity environments, but it delivers clinical information to where it’s needed most,” said Group President Nicholas Ong.

About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Ultraview SL2900.The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.